–Big milestone achieved with fruquintinib successfully approved by US FDA
More visible path to achieve profitability; U/G to BUY
Results inline; solid execution towards achieving development goal
Back to capex growth model to achieve product diversification & overseas expansion
Students Educational Aspirations Are Related to Their Academic Achievement and Parents Education Level
Better profits achieved across 3 business lines
2Q24 sales volume +1%; Full-year target still achievable
Achieving Sustainable and Inclusive Artisanal and Small-Scale Mining (ASM)
Sales exceeding expectations and achieving non-GAAP profitability
3Q24 sales volume accelerated to +21% YoY; on track to achieve target
公众号
小程序
社群
公众号小程序社群